🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Clinical Trials in China / NCT06559319
Active, not recruiting Observational

The Basophil Activation Test For Egg Allergy

NCT06559319 · tracked via the Priya Life Science China tracker
Sponsor
Xia Peng
Phase
Observational
Started
2024-08-10
Last updated
2024-08-21

Condition(s) studied

Food Allergy

Investigational drug(s) / intervention(s)

blood sampling

blood sampling: Venous blood is collected, and sIgE and BAT will be detected using whole blood and serum, respectively.

Study summary

In this study, basophil activation test (BAT) established by the investigators' lab was evaluated for its sensitivity and specificity in child egg allergy diagnosis. Children with suspected IgE mediated allergy to egg will be recruited in the study. Specific IgE to egg allergen and BAT will be detected. The diagnostic accuracy of the BAT will be assessed against clinical diagnosis based on history, clinical symptoms and laboratory results.

Eligibility

Sex
ALL
Min age
4 Months
Max age
6 Years
Healthy volunteers
No
* 1.Children older than 4 months and younger than 6 years old * 2.Suspected egg allergy with one or more of the following complaints after intake of egg: Skin or mucous symptoms (e. g. urticaria, increased eczema, or swollen lips) Respiratory symptoms (tight throat or shortness of breath with signs of bronchial obstruction) loss of consciousness Gastrointestinal symptoms (nausea, vomiting, abdominal pain, diarrhea) Ocular symptoms (conjunctival erythema, pruritus, tears) and other related symptoms * 3\. Sign informed consent by parents/guardians Exclusion Criteria: * 1.Patients with hematological tumors, autoimmune diseases, organ transplantation, and immunodeficiency diseases * 2.Take immunosuppressants, immunomodulators, statins, and inject anesthetics within 3 weeks

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Shanghai General Hospital Shanghai China

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06559319 on ClinicalTrials.gov ↗ ← All trials in China